F Cartier

1.3k total citations
55 papers, 1.0k citations indexed

About

F Cartier is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, F Cartier has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in F Cartier's work include Infective Endocarditis Diagnosis and Management (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (5 papers). F Cartier is often cited by papers focused on Infective Endocarditis Diagnosis and Management (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (5 papers). F Cartier collaborates with scholars based in France, Switzerland and Tunisia. F Cartier's co-authors include C. Michelet, P. Dellamonica, Y Mouton, Patrice Massip, Guy Humbert, Jean Lang, J Modaï, M. Valette, S. Alfandari and H. Portier and has published in prestigious journals such as Clinical Infectious Diseases, Chemical Communications and Journal of Clinical Microbiology.

In The Last Decade

F Cartier

51 papers receiving 959 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F Cartier 472 464 242 120 102 55 1.0k
Ingrid J. B. Spijkerman 475 1.0× 384 0.8× 287 1.2× 80 0.7× 167 1.6× 29 930
F. Raffi 721 1.5× 734 1.6× 220 0.9× 87 0.7× 95 0.9× 71 1.5k
Steve Blum 384 0.8× 331 0.7× 97 0.4× 139 1.2× 90 0.9× 35 962
Raffaella Rosso 501 1.1× 336 0.7× 143 0.6× 80 0.7× 48 0.5× 54 898
Jean‐Louis Vildé 513 1.1× 1.0k 2.2× 372 1.5× 250 2.1× 47 0.5× 32 1.7k
É. Rouveix 464 1.0× 458 1.0× 184 0.8× 78 0.7× 38 0.4× 77 948
Marielle Buisson 492 1.0× 479 1.0× 205 0.8× 48 0.4× 56 0.5× 39 1.1k
David Éverson Uip 336 0.7× 638 1.4× 106 0.4× 187 1.6× 133 1.3× 76 1.1k
Firouzé Bani‐Sadr 502 1.1× 742 1.6× 107 0.4× 80 0.7× 45 0.4× 129 1.4k
Claudio Ucciferri 376 0.8× 342 0.7× 124 0.5× 118 1.0× 53 0.5× 74 1.1k

Countries citing papers authored by F Cartier

Since Specialization
Citations

This map shows the geographic impact of F Cartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Cartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Cartier more than expected).

Fields of papers citing papers by F Cartier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Cartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Cartier. The network helps show where F Cartier may publish in the future.

Co-authorship network of co-authors of F Cartier

This figure shows the co-authorship network connecting the top 25 collaborators of F Cartier. A scholar is included among the top collaborators of F Cartier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Cartier. F Cartier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cartier, F, Isabelle Madelaine, Nicolas Boissel, et al.. (2020). Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers. Cytotherapy. 22(12). 792–801. 6 indexed citations
2.
Loco, Daniele, Riccardo Spezia, F Cartier, Isabelle Chataigner, & Jean‐Philip Piquemal. (2020). Solvation effects drive the selectivity in Diels–Alder reaction under hyperbaric conditions. Chemical Communications. 56(49). 6632–6635. 16 indexed citations
3.
Michelet, C., C. Arvieux, Jean Marc Besnier, et al.. (1998). Opportunistic infections occurring during highly active antiretroviral treatment. AIDS. 12(14). 1815–1822. 148 indexed citations
5.
Mouton, Y, S. Alfandari, M. Valette, et al.. (1997). Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS. 11(12). F101–F105. 313 indexed citations
6.
Colimon, R., S. Minjolle, Patrice André, et al.. (1996). New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus. Journal of Virological Methods. 58(1-2). 7–19. 8 indexed citations
7.
Ruffault, Annick, et al.. (1995). The Prognostic Value of Plasma Viremia in HIV-Infected Patients Under AZT Treatment. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9(3). 243???248–243???248. 11 indexed citations
8.
Bègué, P, B Carbonnelle, F Cartier, et al.. (1995). La tuberculose en France: Comment arrêter l'épidémie actuelle?. Médecine et Maladies Infectieuses. 25(3). 454–478. 9 indexed citations
9.
Camus, Christophe, C. Leport, F. Raffi, et al.. (1993). Sustained Bacteremia in 26 Patients with a Permanent Endocardial Pacemaker: Assessment of Wire Removal. Clinical Infectious Diseases. 17(1). 46–55. 102 indexed citations
10.
Tulzo, Yves Le, Christophe Camus, Reenu Thomas, et al.. (1992). Fatal co-infection with pulmonary tuberculosis and herpes simplex virus 1 pneumonia under steroid treatment. European Respiratory Journal. 5(1). 108–111. 2 indexed citations
11.
Charasse, Christophe, C. Michelet, Yves Le Tulzo, et al.. (1991). Thrombotic Thrombocytopenic Purpura With the Acquired Immunodeficiency Syndrome: A Pathologically Documented Case Report. American Journal of Kidney Diseases. 17(1). 80–82. 9 indexed citations
12.
Launois, B, E. Bardaxoglou, J. P. Campion, et al.. (1990). [Urologic complications after 333 kidney transplantations].. PubMed. 116(3). 282–8; discussion 288. 1 indexed citations
13.
Cartier, F & Bernard Lobel. (1990). [Nosocomial urinary tract infection].. PubMed. 40(14). 1279–84. 2 indexed citations
14.
Bouget, J., R. Thomas, Christophe Camus, J Bousser, & F Cartier. (1989). Intoxication par l'eau chez des malades psychiatriques. La Revue de Médecine Interne. 10(6). 509–514. 14 indexed citations
15.
Launois, B, E. Bardaxoglou, P Prévost, et al.. (1988). [15 years of renal transplantation under conventional immunosuppressive treatment].. PubMed. 114(4). 273–9. 3 indexed citations
16.
Brissot, Pierre, et al.. (1982). [A new case of hepatitis due to glafenine].. PubMed. 6(11). 948–948. 2 indexed citations
17.
Cartier, F, et al.. (1978). [Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 54(25-28). 855–7. 2 indexed citations
18.
Cartier, F, et al.. (1978). [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].. PubMed. 7(2). 97–102. 7 indexed citations
19.
Garré, M, et al.. (1975). [Pneumocystis carinii pneumonia after kidney transplantation. Early diagnosis by distal bronchial brushing].. PubMed. 4(6). 393–4. 2 indexed citations
20.
Cartier, F, et al.. (1965). [Treatment of tetanus in the resuscitation center of the Hôpital Claude-Bernard. I. Information gathered from the 150 most recent cases in a statistical series of 1,000 patients].. PubMed. 73(38). 2153–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026